Rising chronic disease burden is boosting the Personalized Genomics Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Personalized Genomics Market Projected To Become By 2030 Based On Its 2026 Valuation?

The personalized genomics market has experienced rapid expansion in recent years. Its value is projected to increase from $9.45 billion in 2025 to $10.96 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.0%. This historical growth can be attributed to several factors, including the reduction in genetic sequencing costs, the rising incidence of chronic and genetic illnesses, the expansion of research-focused genomics studies, the development of diagnostic laboratory infrastructure, and the early adoption of precision medicine strategies.

The personalized genomics market size is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $19.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.7%. This growth during the forecast period is primarily driven by the incorporation of genomics into standard clinical practice, an increasing need for personalized medicine, breakthroughs in sequencing technologies, the broadening scope of wellness and ancestry testing, and intensified investments from pharmaceutical and biotechnology firms. Significant trends for the forecast period comprise the increasing uptake of direct-to-consumer genetic testing, the expanding application of pharmacogenomics in planning treatments, a heightened demand for preventive and predictive healthcare, the wider application of genetic testing in reproductive health, and a greater consumer understanding of lifestyle and wellness genomics.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

What Primary Drivers Are Shaping The Development Of The Personalized Genomics Market?

The rising prevalence of chronic diseases is anticipated to drive the expansion of the personalized genomics market. Chronic diseases are persistent conditions that demand continuous management and encompass health issues such as diabetes, heart disease, and hypertension. The increase in these conditions is primarily attributable to an aging population, sedentary lifestyles, poor nutritional habits, and environmental elements that contribute to the simultaneous development of multiple ailments. Personalized genomics assists in managing chronic diseases by enabling extensive genotyping and sequencing, which helps categorize patients by their genetic risk, leading to more precise diagnostics, targeted interventions, and improved prevention strategies. For instance, in April 2025, the U.S. Centers for Disease Control and Prevention (CDC), an US-based organization, reported that 76.4% of U.S. adults, roughly 194 million people, had at least one of 12 specific chronic conditions, while 51.4% (around 130 million) had two or more of these conditions. Thus, the increasing occurrence of chronic diseases is a key driver for the personalized genomics market’s growth.

What Segment Groups Are Identified Within The Personalized Genomics Market?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

3) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Coronary Artery Disease Testing

4) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Ancestry Testing

What Trends Are Advancing Progress In The Personalized Genomics Market?

Leading companies in the personalized genomics market are concentrating on developing innovative technologies, such as personalized genomics platforms, to offer customized insights into health, wellness, and disease prevention. A personalized genomics platform constitutes a system that scrutinizes an individual’s genetic data to provide bespoke insights and recommendations pertaining to health, well-being, and susceptibility to illnesses. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostic service provider, launched Geniee Decode Your DNA, a new customized genomics platform. This platform is a personalized genomics system that provides tailored information on health, nutrition, and medication, all based on one’s genetic profile, thereby aiding in optimizing wellness, preventing diseases, and personalizing treatments for improved health outcomes.

Which Companies Hold Significant Positions In The Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

Read the full personalized genomics market report here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

How Does The Personalized Genomics Market Perform Across Major Global Regions?

North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Personalized Genomics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

Browse Through More Reports Similar to the Global Personalized Genomics Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Pharmacogenomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacogenomics-global-market-report

Genomics In Cancer Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795